Updated at 12 p.m. ET
Johnson & Johnson has paused all clinical trials of its experimental COVID-19 vaccine after a study participant became sick with an “unexplained illness.”
In a statement on Monday, the company said it had “temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials,” including a Phase 3 trial that began late last month, while it investigated the illness.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
